Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura (Q33475670)

27 July 2017

Accelerated prostacyclin degradation in the thrombotic thrombocytopenic purpura (English)

1 reference

thrombotic thrombocytopenic purpura

27 July 2017

1 reference

1 reference

Y. C. Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6114320

7 August 2023

B. McLeod

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6114320

7 August 2023

E. R. Hall

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6114320

7 August 2023

K. K. Wu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6114320

7 August 2023

language of work or name

English

0 references

publication date

1 August 1981

1 reference

27 July 2017

8 August 1981

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=6114320

full work available at URL

7 August 2023

https://api.elsevier.com/content/article/PII:S0140673681905225?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(81)90522-5

https://api.elsevier.com/content/article/PII:S0140673681905225?httpAccept=text/plain

7 August 2023

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(81)90522-5

7 August 2023

1 reference

27 July 2017

2

1 reference

27 July 2017

8241

1 reference

27 July 2017

267-269

1 reference

THROMBOTIC THROMBOCYTOPENIC PURPURA

27 July 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Thrombotic thrombocytopenic purpura-like syndrome associated with infective endocarditis. A possible immune complex disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Haemolytic-uraemic syndrome: deficiency of plasma factor(s) regulating prostacyclin activity?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Familial deficiency of a plasma factor stimulating vascular prostacyclin activity

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Aggregation of Blood Platelets by Adenosine Diphosphate and its Reversal

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Human arterial and venous tissues generate prostacyclin (prostaglandin x), a potent inhibitor of platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Treatment of Thrombotic Thrombocytopenic Purpura with Plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

PROSTACYCLIN GENERATION BY CULTURED ENDOTHELIAL CELLS IN HÆMOLYTIC URÆMIC SYNDROME

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Plasma 6-keto-PGF1 alpha levels after plasma exchange in thrombotic thrombocytopenic purpura

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Arachidonic Acid Metabolites and the Interactions between Platelets and Blood-Vessel Walls

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Stability of prostacyclin in plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Human plasma transforms prostacyclin (PGI2) into a platelet antiaggregatory substance which contracts isolated bovine coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Albumins stabilize prostaglandin I2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Stability of prostaglandin I2 in human blood

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Chemical stability of prostacyclin (PGI2) in aqueous solutions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Congenital deficiency of a factor in normal plasma that reverses microangiopathic hemolysis and thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2881%2990522-5

7 January 2021

Dipyridamole and platelet aggregation

16

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(81)90522-5

Evidence for distinct prostaglandin I2 and D2 receptors in human platelets

7 August 2023

18

1 reference

https://api.crossref.org/works/10.1016/S0140-6736(81)90522-5

7 August 2023

Identifiers

1 reference

27 July 2017

1 reference